As with MS, patients with T2D show higher levels of circulating CRP, fibrinogen, plasminogen activator inhibitor (PAI), and proinflammatory cytokines such as interleukin-1β (IL-1β) and IL-6. Here, IL6 is linked to myeloid sarcoma.